...
首页> 外文期刊>Oncology: International Journal of Cancer Research and Treatment >Different expression of nm23-H1 and nm23-H2 protein with proliferative activities in various sizes of human renal cell carcinoma.
【24h】

Different expression of nm23-H1 and nm23-H2 protein with proliferative activities in various sizes of human renal cell carcinoma.

机译:nm23-H1和nm23-H2蛋白在不同大小的人肾细胞癌中的表达具有增殖活性。

获取原文
获取原文并翻译 | 示例
           

摘要

Ninety-five paraffin blocks of renal cell carcinomas (RCCs) and background normal tissue were obtained from patients in Nara Medical University Hospital and used for studying silver-binding nucleolar organizer regions (AgNORs), proliferating cell nuclear antigen (PCNA) and nm23 oncogenes. The RCCs were grouped by size (< or = 30, > 30 and < or = 50, > 50 mm of average diameter) and grade according to the General Rules for Clinical and Pathological Studies of Renal Cell Carcinoma, Japan. Numbers of cases were 17 in the < or = 30-mm group, 36 in the > 30- and < or = 50-mm group, and 42 in the > 50-mm group. AgNOR scores were 4.68 +/- 1.22, 3.91 +/- 1.31 and 3.01 +/- 1.05, respectively, with significant intergroup differences. Frequencies of PCNA-positive cells per 500 cells were 33.8 +/- 23.5, 39.4 +/- 13.8 and 45.9 +/- 38.8. nm23-H1 immunohistochemical staining proved strongly positive in 21 of 24 areas of normal proximal convoluted tubules, 4 of 8 dysplasia cases, 2 of 17 in the < or = 30-mm group RCCs, 1 of 36 in the > 30- and < or = 50-mm group RCCs and none of 42 in the > 50-mm RCCs. nm23-H2 in contrast was weakly positive in 3/24, 2/8, 12/17, 30/36 and 20/42 of the cases, respectively. The results indicated an inverse relationship between tumor size and score of AgNOR without any variation in PCNA labeling and contrasting expression of nm23-H1 and nm23-H2 linked to the size of RCCs.
机译:从奈良医科大学附属医院的患者那里获得了95个肾细胞癌(RCC)和背景正常组织的石蜡块,用于研究银结合核仁组织区(AgNORs),增殖细胞核抗原(PCNA)和nm23癌基因。根据日本肾细胞癌临床和病理研究通则,将RCC按大小(平均直径<或= 30,> 30和<或= 50,> 50 mm)分组。 <或= 30毫米组的病例数为17,> 30毫米和<或= 50毫米组的病例数为36,而> 50毫米的组为42。 AgNOR评分分别为4.68 +/- 1.22、3.91 +/- 1.31和3.01 +/- 1.05,组间差异显着。每500个细胞PCNA阳性细胞的频率为33.8 +/- 23.5、39.4 +/- 13.8和45.9 +/- 38.8。 nm23-H1免疫组织化学染色在正常的近端曲旋小管的24个区域中的21个区域,8个不典型增生病例中的4个,<或= 30 mm组RCC中的17个中的2个,在> 30-和<或= 50毫米组RCC,> 50毫米RCC中没有42个。相反,nm23-H2在3 / 24、2 / 8、12 / 17、30 / 36和20/42的病例中分别呈弱阳性。结果表明,肿瘤大小与AgNOR得分之间呈反比关系,PCNA标记无任何变化,而nm23-H1和nm23-H2的表达与RCC大小相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号